PortfoliosLab logo

Albireo Pharma, Inc. (ALBO)

Equity · Currency in USD · Last updated Feb 1, 2023

Company Info

ISINUS01345P1066
CUSIP01345P106
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$44.66
Year Range$16.32 - $44.66
EMA (50)$31.90
EMA (200)$26.45
Average Volume$399.88K
Market Capitalization$923.25M

ALBOShare Price Chart


Loading data...

ALBOPerformance

The chart shows the growth of $10,000 invested in Albireo Pharma, Inc. in Aug 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $846 for a total return of roughly -91.54%. All prices are adjusted for splits and dividends.


-20.00%0.00%20.00%40.00%60.00%80.00%100.00%SeptemberOctoberNovemberDecember2023
109.93%
-1.89%
ALBO (Albireo Pharma, Inc.)
Benchmark (^GSPC)

ALBOCompare to other instruments

Search for stocks, ETFs, and funds to compare with ALBO

Albireo Pharma, Inc.

ALBOReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M106.66%6.18%
YTD106.66%6.18%
6M128.67%-1.02%
1Y63.59%-8.02%
5Y5.00%7.63%
10Y-6.00%10.40%

ALBOMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
20224.68%-15.82%10.63%5.99%7.60%-2.13%

ALBOSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Albireo Pharma, Inc. Sharpe ratio is 0.54. A Sharpe ratio between 0 and 1.0 is considered sub-optimal.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.500.000.50SeptemberOctoberNovemberDecember2023
0.54
-0.33
ALBO (Albireo Pharma, Inc.)
Benchmark (^GSPC)

ALBODividend History


Albireo Pharma, Inc. doesn't pay dividends

ALBODrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%SeptemberOctoberNovemberDecember2023
-93.49%
-15.01%
ALBO (Albireo Pharma, Inc.)
Benchmark (^GSPC)

ALBOWorst Drawdowns

The table below shows the maximum drawdowns of the Albireo Pharma, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Albireo Pharma, Inc. is 98.99%, recorded on Dec 17, 2015. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-98.99%May 10, 20101413Dec 17, 2015
-34.52%Jan 12, 201019Feb 8, 201059May 4, 201078
-7.66%May 6, 20101May 6, 20101May 7, 20102
-3.64%Jan 5, 20101Jan 5, 20101Jan 6, 20102

ALBOVolatility Chart

Current Albireo Pharma, Inc. volatility is 6.82%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%50.00%100.00%150.00%200.00%250.00%300.00%350.00%SeptemberOctoberNovemberDecember2023
6.82%
16.90%
ALBO (Albireo Pharma, Inc.)
Benchmark (^GSPC)